Brief: Idorsia Announces Positive Phase 3 Precision Study Findings In Obesity-Associated Resistant Hypertension And Ckm Continuum
05/10/2026 16:46
BRIEF-Idorsia Announces Positive Phase 3 Precision Study Findings In Obesity-Associated Resistant Hypertension And Ckm Continuum Oct 5 (Reuters) - IDORSIA LTD IDIA.S:
IDORSIA - ANNOUNCES POSITIVE PHASE 3 PRECISION STUDY FINDINGS IN OBESITY-ASSOCIATED RESISTANT HYPERTENSION AND CKM CONTINUUM
IDORSIA - PRECISION STUDY BASELINE: 69.2% OBESE, 54.1% DIABETES, 22.2% CKD, 19.6% HEART FAILURE
IDORSIA - PRECISION PHASE 3 STUDY CONDUCTED IN EUROPE, NORTH AMERICA, ASIA, AND AUSTRALIA
Source text: ID:nGNX5M4kW8
Further company coverage: IDIA.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))